(Q54535188)
Statements
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer. (English)
Toshio Shimizu
Anthony W Tolcher
Kyriakos P Papadopoulos
Muralidhar Beeram
Drew W Rasco
Lon S Smith
Shelly Gunn
Leslie Smetzer
Theresa A Mays
Brianne Kaiser
Michael J Wick
Cathy Alvarez
Aracely Cavazos
Gina L Mangold
Amita Patnaik
19 January 2012
18
8
2316-2325